850PIntermittent short course enzalutamide in biochemically recurrent prostate cancer: Analysis of PSA recovery, testosterone levels and tolerability. (23rd October 2018) - Al Harthy, M; Singh, H; Karzai, F; Arlen, P; Theoret, M; Marte, J; Bilusic, M; Couvillon, A; Owens, H; Hankin, A; Cordes, L; Rosner, I; et al.